logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Supriya Lifescience Share Price

Supriya Lifescience Ltd.

₹642.85

14.30(2.28%)

Invest in SUPRIYA with up to 2.22x margin.

Trade with MTF
10th Apr 2026 | 1:21 PM
NSE : SUPRIYA
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Supriya Lifescience Performance

Price Movement

₹642.85

₹631.65

₹645.00

↘ Today's Low↗ Today's High

1 Year Performance

₹642.85

₹545.50

₹832.40

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹645.00
Low₹631.65
Open at₹634.95
Prev Close₹628.55
Volumes41.17 K
Avg Price₹641.04
Lower Circuit₹502.85
Upper Circuit₹754.25

Historical Performance

3M High₹775.00
3M Low₹545.50
1 Yr High₹832.40
1 Yr Low₹545.50
3 Yr High₹842.00
3 Yr Low₹206.20
5 Yr High₹842.00
5 Yr Low₹170.15

Supriya Lifescience Fundamentals

Market Cap
Above industry Median
5,058.70 Cr.
PE Ratio (TTM)
Above industry Median
27.30
Dividend Yield
Low in industry
0.20
Net Profit TTM
6.2% incr over last year
185.27
Net Profit Growth
6.2% incr over last year
185.27
PEG Ratio
High in industry
4.40
ROE
29.1% incr over last year
18.85
Operating Revenue TTM
735.46
Operating Revenue Growth
9.7% incr over last year
Book Value
Above industry Median
4.50
MFI
MFI Overbought
76.70
RSI
RSI is mid-range
56.91
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
4.50

Supriya Lifescience Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue206.44199.83145.07184.11185.65
Operating Expense134.36127.1993.37116.52119.70
Operating Profit72.0872.6551.7067.5865.95
Depreciation6.826.646.456.084.96
Interest0.490.420.510.420.51
Tax17.2417.8912.6213.6815.80
Net Profit49.6850.4334.7950.3846.78

Supriya Lifescience Technicals

Supriya Lifescience Ltd. EMA & SMA

₹642.85

5.90 (0.93%)

↗ Bullish Moving Average

9

↘ Bearish Moving Average

7

Day EMA5 ₹614.9
Day EMA10 ₹604.1
Day EMA12 ₹602.6
Day EMA20 ₹604.6
Day EMA26 ₹610
Day EMA50 ₹635.2
Day EMA100 ₹666.4
Day EMA200 ₹678.7

Supriya Lifescience Support and Resistance

Resistance

First Resistance₹645.50
Second Resistance₹654.05
Third Resistance₹665.85

Support

First Support₹625.15
Second Support₹613.35
Third Support₹604.80

Technical Indicators

Day RSI56.91
Day MFI76.70
Day ADX28.86
Day Commodity Channel Index232.10
William-5.48
Day MACD-7.43
Day MACD Signal Line-17.13
Day ATR27.22
Day ROC125-12.88
Day ROC212.03

Supriya Lifescience Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter68.368.368.368.368.368.3
FII66.57.26.85.55.2
DII5.54.94.24.85.25
Public20.220.220.220.12121.5

Supriya Lifescience Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day60.44 K1.12 L54.02%
Week43.47 K98.17 K44.28%
1 Month94.9 K1.77 L53.59%
6 Month1.02 L2.12 L48.07%

Supriya Lifescience SWOT Analysis

Strengths18
Weakness5
Opportunity3
Threats2

Companies with no Debt

Benjamin Graham Value Screen

Consistent high performing stocks over Five Years

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Supriya Lifescience Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
04 Sep, 20251FINAL05 Sep, 2025Equity Share
20 Sep, 20240.8FINALEquity Share
15 Sep, 20230.6FINALEquity Share
01 Sep, 20220.6FINALEquity Share

Supriya Lifescience Stock Comparison

Financials
Corona Remedies Ltd.
Sudeep Pharma Ltd.
Rubicon Research Ltd.
OneSource Specialty Pharma Ltd.
Sanofi Consumer Healthcare India Ltd.
Akums Drugs & Pharmaceuticals Ltd.
Price (₹)₹1,570.30₹621.15₹850.55₹1,362.20₹4,590.10₹512.90
% Change0.54%1.28%-0.66%-0.98%0.47%4.30%
Revenue TTM (₹ Cr)--₹1,598.19₹1,419.33₹878.40₹4,256.70
Net Profit TTM (₹ Cr)--₹206.20₹20.10₹240.10₹318.19
PE TTM--68.60784.4043.8024.30
1 Year Return47.073.4276.54-11.44-6.2110.23
ROCE30.2434.7834.763.26-11.27

Similar Stocks

BLUEJET

Blue Jet Healthcare Ltd

₹ 406.85

+9.99%

CONCORDBIO

Concord Biotech Ltd.

₹ 1059.90

+0.49%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 699.50

+2.72%

PPLPHARMA

Piramal Pharma Ltd.

₹ 146.77

+2.67%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2391.00

+2.97%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1048.65

+0.59%

COHANCE

Cohance Lifesciences Ltd.

₹ 366.05

+15.53%

ERIS

Eris Lifesciences Ltd.

₹ 1371.50

+0.54%

SYNGENE

Syngene International Ltd.

₹ 406.20

+3.33%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 727.55

+1.03%

STAR

Strides Pharma Science Ltd.

₹ 1004.80

+0.86%

GRANULES

Granules India Ltd.

₹ 636.30

+0.13%

FDC

FDC Ltd.

₹ 350.80

+2.99%

SHILPAMED

Shilpa Medicare Ltd.

₹ 419.00

+0.00%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 890.75

+1.34%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1704.10

+2.53%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 14967.00

+1.66%

MARKSANS

Marksans Pharma Ltd.

₹ 179.78

+2.74%

SANOFI

Sanofi India Ltd.

₹ 3490.00

+0.77%

PGHL

Procter & Gamble Health Ltd.

₹ 4943.90

+2.95%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 673.75

+3.52%

FAQ's on SUPRIYA

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy